An observational study evaluating effectiveness and therapeutic adherence in patients with Type 2 Diabetes initiating dulaglutide vs. subcutaneous semaglutide in Spain-Reference-Cited by-同舟云学术

An observational study evaluating effectiveness and therapeutic adherence in patients with Type 2 Diabetes initiating dulaglutide vs. subcutaneous semaglutide in Spain

Published:2021-03 Issue: Volume:2 Page:100082
ISSN:2666-3961
Container-title:Endocrine and Metabolic Science
language:en
Short-container-title:Endocrine and Metabolic Science

Author:

Tofé Santiago^ORCID,Argüelles Iñaki,Mena Elena,Serra Guillermo^ORCID,Codina Mercedes,Urgelés Juan Ramón,García Honorato,Pereg Vicente

Publisher

Elsevier BV

Reference40 articles.

1. Efficacy and safety of once-weekly Semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial;Ahmann;Diabetes Care.,2018

2. Efficacy and safety of onceweekly Semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial;Ahrén;Lancet Diabetes Endocrinol.,2017

3. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide;Alatorre;Diabetes Obes. Metab.,2017

4. 9. Pharmacologic approaches to glycemic treatment: standards of Medical Care in Diabetes-2019;Diabetes Care.,2019

5. Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis;Andreadis;Diabetes Obes. Metab.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective;Journal of Basic and Clinical Physiology and Pharmacology;2024-06-11

2. Pharmacotherapy for older people with obesity;European Journal of Internal Medicine;2024-06

3. Clinical Characteristics Associated with Adherence and Persistence in Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide;Journal of Diabetes Research;2023-06-01

4. Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients;Journal of Endocrinological Investigation;2022-04-16

5. Adherence and persistence rates of major antidiabetic medications: a review;Diabetology & Metabolic Syndrome;2022-01-15